Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study

  • Amy Paller (Creator)
  • Carsten Flohr (Creator)
  • Lawrence Eichenfield (Creator)
  • Jamie Weisman (Creator)
  • Jennifer Soung (Creator)
  • Chitra R. Natalie (Creator)
  • Claudia Rodriguez Capriles (Creator)
  • Evangeline J. Pierce (Creator)
  • Sarah Reifeis (Creator)
  • Renata Gontijo Lima (Creator)
  • Vivian Laquer (Creator)
  • Stephan Weidinger (Creator)

Dataset

Description

Article full text The above Video Abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
Date made available2023
PublisherAdis Journals

Access Dataset

Cite this